logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Jump to: Company in focus, Offsprings
Parent entities and officers 11
  • 1
    Clancy, Marc James, Prof.
    Surgeon born in October 1968
    Individual (1 offspring)
    Officer
    2024-12-17 ~ 2025-09-22
    OF - Director → CIF 0
  • 2
    Stellman, Douglas Colin Walter
    Born in October 1961
    Individual (9 offsprings)
    Officer
    2021-07-22 ~ now
    OF - Director → CIF 0
  • 3
    Fildes, James Edward, Dr
    Born in December 1975
    Individual (2 offsprings)
    Officer
    2018-03-27 ~ now
    OF - Director → CIF 0
    Dr James Edward Fildes
    Born in December 1975
    Individual (2 offsprings)
    Person with significant control
    2018-03-27 ~ now
    PE - Ownership of shares – More than 50% but less than 75% → CIF 0
    PE - Ownership of voting rights - More than 50% but less than 75% → CIF 0
    PE - Right to appoint or remove directors → CIF 0
  • 4
    Claydon, Mark Roy
    Born in March 1974
    Individual (7 offsprings)
    Officer
    2021-07-22 ~ now
    OF - Director → CIF 0
  • 5
    Stone, John Philip, Dr
    Director born in December 1987
    Individual (2 offsprings)
    Officer
    2018-03-27 ~ 2021-06-21
    OF - Director → CIF 0
  • 6
    Jean, Thierry
    Executive Advisor born in July 1956
    Individual (1 offspring)
    Officer
    2024-12-17 ~ 2025-09-22
    OF - Director → CIF 0
  • 7
    Russell, Leslie James, Dr
    Born in January 1953
    Individual (12 offsprings)
    Officer
    2024-12-17 ~ now
    OF - Director → CIF 0
  • 8
    Entwistle, Timothy Rys, Dr
    Director born in January 1975
    Individual (2 offsprings)
    Officer
    2018-03-27 ~ 2021-06-21
    OF - Director → CIF 0
  • 9
    Flinn, Anthony
    Company Director born in October 1958
    Individual (16 offsprings)
    Officer
    2022-11-01 ~ 2024-12-05
    OF - Director → CIF 0
  • 10
    Smith, Richard Henry
    Born in March 1968
    Individual (5 offsprings)
    Officer
    2024-03-04 ~ 2026-03-27
    OF - Director → CIF 0
  • 11
    Nation, Michael Lindsay
    Born in May 1960
    Individual (4 offsprings)
    Officer
    2024-12-17 ~ 2026-03-27
    OF - Director → CIF 0
parent relation
Company in focus

PEBBLE BIOTECHNOLOGY LABORATORIES LTD

Period: 2022-11-03 ~ now
Company number: 11278041
Registered names
PEBBLE BIOTECHNOLOGY LABORATORIES LTD - now
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Property, Plant & Equipment
36,464 GBP2025-03-31
38,703 GBP2024-03-31
Debtors
134,526 GBP2025-03-31
135,463 GBP2024-03-31
Cash at bank and in hand
38,472 GBP2025-03-31
58,100 GBP2024-03-31
Current Assets
186,295 GBP2025-03-31
193,563 GBP2024-03-31
Creditors
Amounts falling due within one year
-201,775 GBP2025-03-31
-185,027 GBP2024-03-31
Net Current Assets/Liabilities
-15,480 GBP2025-03-31
8,536 GBP2024-03-31
Total Assets Less Current Liabilities
20,984 GBP2025-03-31
47,239 GBP2024-03-31
Equity
Called up share capital
21 GBP2025-03-31
21 GBP2024-03-31
Share premium
165,045 GBP2025-03-31
165,045 GBP2024-03-31
Retained earnings (accumulated losses)
-144,082 GBP2025-03-31
-117,827 GBP2024-03-31
Equity
20,984 GBP2025-03-31
47,239 GBP2024-03-31
Average Number of Employees
102024-04-01 ~ 2025-03-31
102023-04-01 ~ 2024-03-31
Property, Plant & Equipment - Gross Cost
Land and buildings
18,613 GBP2025-03-31
18,613 GBP2024-03-31
Other
34,956 GBP2025-03-31
28,873 GBP2024-03-31
Property, Plant & Equipment - Gross Cost
53,569 GBP2025-03-31
47,486 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Land and buildings
2,521 GBP2025-03-31
660 GBP2024-03-31
Other
14,584 GBP2025-03-31
8,123 GBP2024-03-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
17,105 GBP2025-03-31
8,783 GBP2024-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Land and buildings
1,861 GBP2024-04-01 ~ 2025-03-31
Other
6,461 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
8,322 GBP2024-04-01 ~ 2025-03-31
Property, Plant & Equipment
Land and buildings
16,092 GBP2025-03-31
17,953 GBP2024-03-31
Other
20,372 GBP2025-03-31
20,750 GBP2024-03-31
Trade Debtors/Trade Receivables
Current
7,982 GBP2025-03-31
25,580 GBP2024-03-31
Amount of corporation tax that is recoverable
Current
90,083 GBP2025-03-31
96,051 GBP2024-03-31
Other Debtors
Current, Amounts falling due within one year
36,461 GBP2025-03-31
13,832 GBP2024-03-31
Debtors
Current, Amounts falling due within one year
134,526 GBP2025-03-31
135,463 GBP2024-03-31
Bank Borrowings/Overdrafts
Current
182 GBP2025-03-31
0 GBP2024-03-31
Trade Creditors/Trade Payables
Current
93,810 GBP2025-03-31
45,958 GBP2024-03-31
Other Taxation & Social Security Payable
Current
76,127 GBP2025-03-31
40,899 GBP2024-03-31
Other Creditors
Current
31,656 GBP2025-03-31
98,170 GBP2024-03-31
Par Value of Share
Class 1 ordinary share
0.01 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
186,418 shares2025-03-31
186,418 shares2024-03-31
Par Value of Share
Class 2 ordinary share
0.01 GBP2024-04-01 ~ 2025-03-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
25,392 shares2025-03-31
25,392 shares2024-03-31
Equity
Called up share capital
21 GBP2025-03-31
21 GBP2024-03-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
165,501 GBP2025-03-31
195,055 GBP2024-03-31
  • PEBBLE BIOTECHNOLOGY LABORATORIES LTD
    Info
    PERFUSION BIOTECHNOLOGY LTD - 2022-11-03
    PERFUSION RESEARCH LTD - 2022-11-03
    Registered number 11278041
    122, Beech Court Hollin Lane, Styal, Wilmslow SK9 4LD
    PRIVATE LIMITED COMPANY incorporated on 2018-03-27 (8 years 2 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2026-03-26
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

qrcode

Privacy notice

Terms and conditions

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.